http://articles.mercola.com/sites/articles/archive/2008/01/02/fda-votes-on-celebrex-alternate.aspxAn advisory panel to the Food and Drug Administration's (FDA) recommended approval of rofecoxib (Vioxx), the newest of the Cox-2 inhibitors, a class of pain reliever believed to be less damaging to the stomach than aspirin or similar drugs. The FDA oftenenCommunityServer 2008.5 SP1 (Build: 31106.3070)